a public good project by the
Synthesis
Company
of California

© 2026

TJ Smilde | doi.page

0 works0 citations0 h-index

TJ Smilde

European Organisation for Research and Treatment of Cancer(NL)The University of Texas MD Anderson Cancer Center(US)The Netherlands Cancer Institute(NL)Dana-Farber Cancer Institute(US)Cancer Genomics Centre(NL)

Publications by Year

Research Areas

Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology, Cardiovascular Health and Disease Prevention, Breast Lesions and Carcinomas

Most-Cited Works

→ Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial(2001)920 cited
→ In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium(2015)80 cited
→ Abstract P5-23-01: Clinical and biological characterization of male breast cancer (BC) EORTC 10085/TBCRC 029/BOOG 2013-02/BIG 2-07: Baseline results from the prospective registry(2018)3 cited
→ Abstract P1-11-10: Sequential Versus Upfront Intensified Neoadjuvant Chemotherapy in Patients with Large Resectable or Locally Advanced Breast Cancer (INTENS), First Results from a Phase III Study of the Dutch Breast Cancer Trialists’ Group (BOOG)(2010)3 cited
→ Abstract P6-07-32: Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2 positive subtype is associated with the most favorable outcome(2012)1 cited

[Three patients with massive pulmonary embolism].

(2002)

→ Abstract P5-14-01: Chemotherapy randomization of the EORTC 10041/ BIG 3-04 MINDACT (microarray in node-negative and 1 to 3 positive lymph node disease may avoid chemotherapy) trial(2017)

→ Abstract P1-14-07: Neoadjuvant chemotherapy and pathologic complete response in relation to the clinical response, results from a phase III study (INTENS) of the Dutch breast cancer trialists' group (BOOG).(2012)

Non-invasive measurements of atherosclerosis in patients at risk of cardiovascular disease: effects of intervention(2001)

→ Abstract P3-13-11: Unexpected large treatment and outcome variations in metastatic breast cancer: Results of a hormone receptor positive cohort study in the Netherlands(2013)